StemCells Company Description
StemCells hopes a small focus will mean big business. The company discovers cell-based therapies to treat diseases of the central nervous system (CNS), such as cerebral palsy and Alzheimer's disease, as well as spinal cord injury. It is researching stem cell and progenitor cell (cells that have developed from stem cells) therapies to repair neural tissue damaged by disease and injury, and has discovered markers for CNS stem cells and a way to reproduce them for transplant. Its lead therapy candidate may treat Batten disease, a fatal genetic enzyme deficiency. In addition to its CNS research, StemCells is also studying liver cells, hoping to find treatments for diseases such as hepatitis and liver cancer.
View the Comprehensive Company Description for StemCells
The Company Description provides a historical perspective of StemCells's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of StemCells's evolution in the marketplace.
